In the wake of the death of over 20 children due to ‘toxic’ Coldrif, the central government has reportedly proposed the cancellation of the license of Tamil Nadu-based Sresan Pharmaceuticals. However, the final decision is up to the state drug regulator, according to Health Ministry sources on Wednesday, as reported by IANS.

Centre proposes Coldrif ban, leaves decision on Tamil Nadu

Sources from the Health Ministry said that CDSCO has already recommended cancellation of the license for the faulty drug maker, but the final call must be taken by the Tamil Nadu FDA. “Form 25 or a license to manufacture common formulation allopathic drugs is given by the state drug controllers and is governed by them. The cancellation too has to be done by the state drug controller,” the sources said.

It ad

See Full Page